Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
39M
-
Shares change
-
-525K
-
Total reported value, excl. options
-
$316M
-
Value change
-
+$3.21M
-
Put/Call ratio
-
0.76
-
Number of buys
-
74
-
Number of sells
-
-32
-
Price
-
$8.09
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q1 2019
138 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q1 2019.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39M shares
of 119M outstanding shares and own 32.71% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.86M shares), VANGUARD GROUP INC (3.81M shares), BVF INC/IL (3.8M shares), WASATCH ADVISORS INC (3.19M shares), STATE STREET CORP (2.04M shares), FMR LLC (1.93M shares), Foresite Capital Management IV, LLC (1.72M shares), LANSDOWNE PARTNERS (UK) LLP (1.46M shares), MILLENNIUM MANAGEMENT LLC (924K shares), and RP Management, LLC (876K shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.